Hyponatremia and perioperative complications in patients with head and neck squamous cell carcinoma

被引:13
|
作者
Feinstein, Aaron J. [1 ]
Davis, John [1 ]
Gonzalez, Lyndon [1 ]
Blackwell, Keith E. [1 ]
Abemayor, Elliot [1 ,2 ]
Mendelsohn, Abie H. [1 ,2 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, 924 Westwood Blvd,Suite 515, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA
关键词
hyponatremia; squamous cell carcinoma; cancer; complication; surgery; MORTALITY; IMPACT;
D O I
10.1002/hed.24229
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Recent studies suggest that hyponatremia is associated with perioperative morbidity and mortality after general surgical procedures, as well as mortality among medical inpatients. We investigated the association of hyponatremia with perioperative complications in patients undergoing surgical resection of head and neck squamous cell carcinoma (HNSCC). Methods. All patients with pathologically confirmed HNSCC undergoing either primary or salvage surgical resection from March 1, 2013, until May 31, 2014, at a single tertiary care academic center were included in this retrospective review. The primary outcome was 30-day mortality. Secondary outcomes included postoperative complications (respiratory, cardiac, renal, and wound), hospital and intensive care unit (ICU) length of stay, and need for blood transfusion. Results. Two hundred fourteen surgical patients with HNSCC were identified for analysis. Patient ages ranged from 22 to 100 years (mean, 67 years). One hundred thirty-eight men and 76 women were included. Primary tumor sites were oral cavity (47.7%), oropharynx (18.7%), larynx (12.6%), salivary glands (7.9%), cutaneous (7.5%), sinonasal (2.8%), and hypopharynx (2.3%). Surgical resections were balanced between primary (48.1%) and salvage (51.9%). Thirty-five patients (16.4%) carried a presurgical diagnosis of diabetes. Fifteen patients (7.0%) demonstrated preoperative hyponatremia, and 46 (24.9%) had postoperative hyponatremia. Within the primary outcome measure, no difference in mortality was identified. Complications were noted in 58 patients (27.1%), and were more frequent in hyponatremic patients, both preoperatively and postoperatively (60.0% and 41.3%, respectively). Binomial logistic regression demonstrated risk of complications significantly associated with preoperative hyponatremia (odds ratio [OR]=4.374; 95% confidence interval [CI]=1.231-15.545; p=.023), increasing age (OR=1.385; 95% CI=1.032-1.857; p=.030), and increasing length of surgery (OR=1.234; 95% CI=1.046-1.455; p=.013). Postoperative hyponatremia was associated with increased hospital length of stay (p=.034). Conclusion. Hyponatremia is a frequent electrolyte abnormality in patients with HNSCC. Both preoperative and postoperative hyponatremia are associated with perioperative morbidity, thus meriting intensive postoperative medical monitoring and treatment. Additional investigation is warranted to identify the pathophysiologic mechanisms behind this association. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:E1370 / E1374
页数:5
相关论文
共 50 条
  • [31] Afatinib in squamous cell carcinoma of the head and neck
    Specenier, Pol
    Vermorken, Jan
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1295 - 1301
  • [32] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Hoesli R.C.
    Moyer J.S.
    Current Oral Health Reports, 2016, 3 (2) : 74 - 81
  • [33] Head and neck squamous cell carcinoma in childhood
    de Carvalho, MB
    Sobrinho, JD
    Rapoport, A
    Fava, AS
    Mendes, AF
    Kanda, JL
    Lehn, CN
    Chacra, J
    Menezes, MB
    Walder, F
    Franzi, SA
    MEDICAL AND PEDIATRIC ONCOLOGY, 1998, 31 (02): : 96 - 99
  • [34] Docetaxel and squamous cell carcinoma of the head and neck
    Calais, G
    BULLETIN DU CANCER, 2004, 91 (02) : 167 - 171
  • [35] Immunotherapy for squamous cell carcinoma of the head and neck
    Yokota, Tomoya
    Homma, Akihiro
    Kiyota, Naomi
    Tahara, Makoto
    Hanai, Nobuhiro
    Asakage, Takahiro
    Matsuura, Kazuto
    Ogawa, Takenori
    Saito, Yuki
    Sano, Daisuke
    Kodaira, Takeshi
    Motegi, Atsushi
    Yasuda, Koichi
    Takahashi, Shunji
    Tanaka, Kaoru
    Onoe, Takuma
    Okano, Susumu
    Imamura, Yoshinori
    Ariizumi, Yosuke
    Hayashi, Ryuichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (10) : 1089 - 1096
  • [36] Angiogenesis in head and neck squamous cell carcinoma
    Homer, JJ
    Greenman, J
    Stafford, ND
    CLINICAL OTOLARYNGOLOGY, 2000, 25 (03): : 169 - 180
  • [37] Retreatment in head and neck squamous cell carcinoma
    Bourhis, J
    DeCrevoisier, R
    Eschwege, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S129 - S130
  • [38] Oligometastasis in Head and Neck Squamous Cell Carcinoma
    Moon, Dominic H.
    Sher, David J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (04): : 803 - 811
  • [39] Squamous cell carcinoma of the head and neck in the elderly
    Gugic, Jasenka
    Strojan, Primoz
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2013, 18 (01) : 16 - 25
  • [40] Immunotherapy for head and neck squamous cell carcinoma
    Li, Qiao
    Prince, Mark E. P.
    Moyer, Jeffrey S.
    ORAL ONCOLOGY, 2015, 51 (04) : 299 - 304